Literature DB >> 6275972

Effect of enflurane and fentanyl on the clinical characteristics of long-term succinylcholine infusion.

F Donati, D R Bevan.   

Abstract

The characteristics of the neuromuscular block produced by prolonged succinylcholine infusion were compared in 40 patients anaesthetized with either nitrous oxide with enflurane (1-2 per cent inspired) or nitrous oxide and fentanyl. Neuromuscular transmission was monitored using train-of-four stimulation and the infusion rate was adjusted to keep the first twitch at 10-15 per cent of its control value. Initially, all patients, exhibited a depolarizing-type block all twitches of the train-of-four being roughly the same size, and the infusion rates were similar in the enflurane (54 microgram X kg-1/min) and the fentanyl (58 microgram X kg-1/min) groups. Tachyphylaxis developed later in both groups and correlated well with the onset of phase II block (dual block). This occurred sooner and at a lower cumulative dose in the enflurane group. Fourth to first twitch ratios decreased to 50, 25 and 0 per cent in 31, 46 and 59 minutes in the enflurane group, at cumulative succinylcholine doses of 2.2, 3.2 and 4.2 mg X kg-1 respectively. Corresponding figures for the fentanyl group were 52, 73 and 86 minutes, with dose of 3.4, 5.0 and 5.9 mg X kg-1. Infusion rates increased markedly after establishment of dual block, but were similar with enflurane (0.99 mg X kg-1/min) and fentanyl (1.12 mg X kg-1/min). Ten minutes after stopping the infusion fourth to first twitch ratios failed to reach 50 per cent in most patients given enflurane who had received more than 6 mg X kg-1 succinylcholine over more than 90 minutes. Corresponding figures for fentanyl patients were 13 mg x kg-1 and 150 minutes. The block in all 15 patients (9 enflurane, 6 fentanyl) who did not recover spontaneously was successfully antagonized with atropine and neostigmine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6275972     DOI: 10.1007/bf03007950

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  10 in total

1.  Magnitude, dose-requirement and mode of development of tachyphylaxis to suxamethonium in man.

Authors:  C Lee; A Barnes; R L Katz
Journal:  Br J Anaesth       Date:  1978-02       Impact factor: 9.166

2.  Flow requirements for a modified Mapleson D system during controlled ventilation.

Authors:  J A Bain; W E Spoerel
Journal:  Can Anaesth Soc J       Date:  1973-09

3.  Depression of twitch response to stimulation of the ulnar nerve during ethrane anesthesia in man.

Authors:  M H Lebowitz; C D Blitt; L F Walts
Journal:  Anesthesiology       Date:  1970-07       Impact factor: 7.892

4.  Stimulus frequency in the detection of neuromuscular block in humans.

Authors:  H H Ali; J E Utting; C Gray
Journal:  Br J Anaesth       Date:  1970-11       Impact factor: 9.166

5.  Neuromuscular pharmacology. A clinical update and commentary.

Authors:  C Lee; R L Katz
Journal:  Br J Anaesth       Date:  1980-02       Impact factor: 9.166

6.  Dose relationships of phase II, tachyphylaxis and train-of-four fade in suxamethonium-induced dual neuromuscular block in man.

Authors:  C Lee
Journal:  Br J Anaesth       Date:  1975-08       Impact factor: 9.166

7.  Neuromuscular effects of enflurane, alone and combined with d-Tubocurarine, pancuronium, and succinylcholine, in man.

Authors:  R P Fogdall; R D Miller
Journal:  Anesthesiology       Date:  1975-02       Impact factor: 7.892

8.  Characteristics of succinylcholine-produced phase II neuromuscular block during enflurane, halothane, and fentanyl anesthesia.

Authors:  J C Hilgenberg; R K Stoelting
Journal:  Anesth Analg       Date:  1981-04       Impact factor: 5.108

9.  Train-of-four fade and edrophonium antagonism of neuromuscular block by succinylcholine in man.

Authors:  C Lee
Journal:  Anesth Analg       Date:  1976 Sep-Oct       Impact factor: 5.108

10.  Clinical characteristics of long-term succinylcholine neuromuscular blockade during balanced anesthesia.

Authors:  F M Ramsey; P W Lebowitz; J J Savarese; H H Ali
Journal:  Anesth Analg       Date:  1980-02       Impact factor: 5.108

  10 in total
  6 in total

Review 1.  Drug interactions with neuromuscular blockers.

Authors:  S Feldman; L Karalliedde
Journal:  Drug Saf       Date:  1996-10       Impact factor: 5.606

Review 2.  Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  W J Book; M Abel; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

3.  Neuromuscular blockade in infants following intramuscular succinylcholine in two or five per cent concentration.

Authors:  G A Sutherland; J C Bevan; D R Bevan
Journal:  Can Anaesth Soc J       Date:  1983-07

4.  Succinylcholine apnoea: attempted reversal with anticholinesterases.

Authors:  D R Bevan; F Donati
Journal:  Can Anaesth Soc J       Date:  1983-09

Review 5.  The use of muscle relaxants in the intensive care unit.

Authors:  M D Sharpe
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

6.  Neostigmine antagonism of succinylcholine phase II block: a comparison with pancuronium.

Authors:  M E Futter; F Donati; A S Sadikot; D R Bevan
Journal:  Can Anaesth Soc J       Date:  1983-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.